EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access · CC BY 4.0

A qualitative study to investigate pharmacovigilance systems in Dubai hospitals

Sawsan Shanableh, Muaed Jamal Alomar iD, Hadzliana Zainail

PLOS One · 2025

DOI: 10.1371/journal.pone.0331929 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift PLOS One, 2025. Verfasst von Sawsan Shanableh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates. Hauptthemen laut MEDLINE: Pharmacovigilance, Adverse Drug Reaction Reporting Systems, Drug-Related Side Effects and Adverse Reactions. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ensuring the safety of medications is a significant public health priority, with developed countries implementing robust pharmacovigilance programs. Despite this, healthcare providers continue to underreport adverse drug reactions (ADRs). This study aims to explore the existing pharmacovigilance system and procedure followed for ADR reporting in selected Dubai hospitals. It also identifies the obstacles that may negatively influence ADR reporting.

Methods

This study was conducted using a qualitative methodology involving in-depth interviews. Convenience sampling was used to select and interview chief hospital pharmacists in Dubai using a semi-structured interview guide. Every interview was audio recorded, verbatim transcribed, and then subjected to a thematic content analysis. The data were analyzed manually by the reading and re-reading of the interviews, and an inductive and flexible approach was undertaken by the research team.

Results

A total of ten individuals, three chief pharmacists and seven pharmacy managers were interviewed. Seven themes emerged from the interviews’ thematic content analysis, including: (1) Existence of a pharmacovigilance center or unit, (2) Experience with medication safety & ADR concept, (3) Current ADR reporting process in the hospital setting, (4) Barriers to adverse drug reaction reporting, (5) Policy change needs, (6) The factors that could enhance ADR reporting, and (7) Future pharmacovigilance research needs in the UAE. Eight hospitals have ADR reporting systems in their hospital policies while two hospitals don’t have any pharmacovigilance system. Of the eight hospitals, seven have their own software for ADR reporting and one used paper form. Based on the participants feedback, six have full experience with ADR reporting process, while others have partial or don’t have any idea about reporting process. ADR reporting is hindered by a number of factors, such as inadequate awareness and training for pharmacovigilance and ADR reporting process, a communication gap between hospitals and regulatory bodies, time constraints due to numerous responsibilities, and fear of punishment.

Conclusion

The study found that although hospital pharmacists have a good understanding of medication safety and ADR reporting, they do not actually apply this knowledge into practice. Ongoing training and education on the ADR reporting process have the potential to improve attitudes toward ADR reporting and actively engage individuals in ensuring medication safety within hospital settings. The participation of key stakeholders from the Ministry of Health, academia, the pharmaceutical companies, and healthcare professionals is essential to support the safe and effective use of medications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacovigilanceAdverse Drug Reaction Reporting SystemsDrug-Related Side Effects and Adverse ReactionsHumansQualitative ResearchPharmacistsHospitalsFemaleMale

Autor:innen und Institutionen

  • Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates.
  • Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, University Sains Malaysia, Penang, Malaysia.

ORCID-Profile: Muaed Jamal Alomar

Zitieren

APA

Shanableh, S., Alomar, M. J., & Zainail, H. (2025). A qualitative study to investigate pharmacovigilance systems in Dubai hospitals. PLOS One. https://doi.org/10.1371/journal.pone.0331929

Vancouver

Shanableh S, Alomar MJ, Zainail H. A qualitative study to investigate pharmacovigilance systems in Dubai hospitals. PLOS One. 2025. doi:10.1371/journal.pone.0331929

BibTeX
@article{Shanableh2025,
  author = {Shanableh, Sawsan and Alomar, Muaed Jamal and Zainail, Hadzliana},
  title = {A qualitative study to investigate pharmacovigilance systems in Dubai hospitals},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0331929}
}
Kostenlos starten →